Simplex Trading’s RAPT Therapeutics RAPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-1,800
| Closed | -$61K | – | 9946 |
|
|
2025
Q4 | $61K | Sell |
1,800
-13,900
| -89% | -$432K | ﹤0.01% | 5482 |
|
|
2025
Q3 | $404K | Buy |
15,700
+15,100
| +2,517% | +$198K | ﹤0.01% | 4098 |
|
|
2025
Q2 | $4K | Buy |
600
+475
| +380% | +$3.62K | ﹤0.01% | 7883 |
|
|
2025
Q1 | $1K | Sell |
125
-7,450
| -98% | -$73.3K | ﹤0.01% | 8291 |
|
|
2024
Q4 | $95K | Buy |
7,575
+7,387
| +3,929% | +$93.8K | ﹤0.01% | 5217 |
|
|
2024
Q3 | $3K | Sell |
188
-587
| -76% | -$11.9K | ﹤0.01% | 7878 |
|
|
2024
Q2 | $18K | Buy |
775
+112
| +17% | +$5.17K | ﹤0.01% | 6995 |
|
|
2024
Q1 | $47K | Sell |
663
-962
| -59% | -$134K | ﹤0.01% | 6314 |
|
|
2023
Q4 | $323K | Buy |
1,625
+1,075
| +195% | +$133K | ﹤0.01% | 4145 |
|
|
2023
Q3 | $73K | Sell |
550
-1,850
| -77% | -$302K | ﹤0.01% | 5431 |
|
|
2023
Q2 | $359K | Sell |
2,400
-63
| -3% | -$9.81K | ﹤0.01% | 3648 |
|
|
2023
Q1 | $361K | Buy |
2,463
+2,038
| +480% | +$412K | ﹤0.01% | 3619 |
|
|
2022
Q4 | $67K | Sell |
425
-100
| -19% | -$16K | ﹤0.01% | 5520 |
|
|
2022
Q3 | $101K | Sell |
525
-488
| -48% | -$92.3K | ﹤0.01% | 5515 |
|
|
2022
Q2 | $147K | Buy |
1,013
+1,000
| +7,692% | +$133K | ﹤0.01% | 5030 |
|
|
2022
Q1 | $2K | Sell |
13
-1,475
| -99% | -$279K | ﹤0.01% | 9915 |
|
|
2021
Q4 | $437K | Sell |
1,488
-9,437
| -86% | -$2.52M | ﹤0.01% | 4003 |
|
|
2021
Q3 | $2.69M | Hold |
10,925
| – | – | ﹤0.01% | 1791 |
|
|
2021
Q2 | $2.78M | Buy |
10,925
+10,919
| +181,983% | +$2.04M | ﹤0.01% | 1765 |
|
|
2021
Q1 | $104K | Sell |
6
-1
| -14% | -$165 | ﹤0.01% | 5703 |
|
|
2020
Q4 | $114K | Buy |
+7
| New | +$1.52K | ﹤0.01% | 5316 |
|
Simplex Trading's RAPT Position: Q1 2026 in Review
Simplex Trading sold out of RAPT Therapeutics (RAPT) in Q1 2026, closing a stake of 2,846 shares — an estimated $96.4K sold.
Simplex Trading first reported a position in RAPT in Q4 2020 and held it in 13 quarters. The position peaked at $1.47M in Q3 2021. 0 funds tracked by Wall St. Rank hold RAPT as of Q1 2026.
- Simplex Trading reported no remaining RAPT Therapeutics position as of Q1 2026 after selling out during the quarter.
- Simplex Trading sold 2,846 RAPT Therapeutics shares in Q1 2026, an estimated $96.4K.
- Simplex Trading first reported a position in RAPT Therapeutics in Q4 2020 and held it in 13 quarters.
- Simplex Trading's RAPT Therapeutics position peaked at $1.47M in Q3 2021.
- 0 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q1 2026.
Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.